Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 170

1.

Trends in intussusception hospitalizations among US infants, 1993-2004: implications for monitoring the safety of the new rotavirus vaccination program.

Tate JE, Simonsen L, Viboud C, Steiner C, Patel MM, Curns AT, Parashar UD.

Pediatrics. 2008 May;121(5):e1125-32. doi: 10.1542/peds.2007-1590.

2.

Hospitalizations for intussusception before and after the reintroduction of rotavirus vaccine in the United States.

Zickafoose JS, Benneyworth BD, Riebschleger MP, Espinosa CM, Davis MM.

Arch Pediatr Adolesc Med. 2012 Apr;166(4):350-5. doi: 10.1001/archpediatrics.2011.1501. Epub 2012 Jan 2.

3.

Trends in intussusception hospitalizations among US infants before and after implementation of the rotavirus vaccination program, 2000-2009.

Yen C, Tate JE, Steiner CA, Cortese MM, Patel MM, Parashar UD.

J Infect Dis. 2012 Jul 1;206(1):41-8. doi: 10.1093/infdis/jis314. Epub 2012 Apr 26.

4.

Intussusception-associated hospitalization among Venezuelan infants during 1998 through 2001: anticipating rotavirus vaccines.

Pérez-Schael I, Escalona M, Salinas B, Materán M, Pérez ME, González G.

Pediatr Infect Dis J. 2003 Mar;22(3):234-9.

PMID:
12634584
5.

An analysis of rotavirus vaccine reports to the vaccine adverse event reporting system: more than intussusception alone?

Haber P, Chen RT, Zanardi LR, Mootrey GT, English R, Braun MM; VAERS Working Group.

Pediatrics. 2004 Apr;113(4):e353-9.

PMID:
15060267
6.

Analysis of hospitalizations due to intussusception in Sicily in the pre-rotavirus vaccination era (2003-2012).

Costantino C, Restivo V, Cuccia M, Furnari R, Amodio E, Vitale F.

Ital J Pediatr. 2015 Aug 1;41:52. doi: 10.1186/s13052-015-0160-4.

7.

Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants.

Shui IM, Baggs J, Patel M, Parashar UD, Rett M, Belongia EA, Hambidge SJ, Glanz JM, Klein NP, Weintraub E.

JAMA. 2012 Feb 8;307(6):598-604. doi: 10.1001/jama.2012.97.

PMID:
22318281
8.

Potential intussusception risk versus benefits of rotavirus vaccination in the United States.

Desai R, Cortese MM, Meltzer MI, Shankar M, Tate JE, Yen C, Patel MM, Parashar UD.

Pediatr Infect Dis J. 2013 Jan;32(1):1-7. doi: 10.1097/INF.0b013e318270362c.

PMID:
22929172
9.

All-cause gastroenteritis and rotavirus-coded hospitalizations among US children, 2000-2009.

Desai R, Curns AT, Steiner CA, Tate JE, Patel MM, Parashar UD.

Clin Infect Dis. 2012 Aug;55(4):e28-34. doi: 10.1093/cid/cis443. Epub 2012 Apr 27.

10.

Intussusception, rotavirus diarrhea, and rotavirus vaccine use among children in New York state.

Chang HG, Smith PF, Ackelsberg J, Morse DL, Glass RI.

Pediatrics. 2001 Jul;108(1):54-60.

PMID:
11433054
11.

Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil.

Patel MM, López-Collada VR, Bulhões MM, De Oliveira LH, Bautista Márquez A, Flannery B, Esparza-Aguilar M, Montenegro Renoiner EI, Luna-Cruz ME, Sato HK, Hernández-Hernández Ldel C, Toledo-Cortina G, Cerón-Rodríguez M, Osnaya-Romero N, Martínez-Alcazar M, Aguinaga-Villasenor RG, Plascencia-Hernández A, Fojaco-González F, Hernández-Peredo Rezk G, Gutierrez-Ramírez SF, Dorame-Castillo R, Tinajero-Pizano R, Mercado-Villegas B, Barbosa MR, Maluf EM, Ferreira LB, de Carvalho FM, dos Santos AR, Cesar ED, de Oliveira ME, Silva CL, de Los Angeles Cortes M, Ruiz Matus C, Tate J, Gargiullo P, Parashar UD.

N Engl J Med. 2011 Jun 16;364(24):2283-92. doi: 10.1056/NEJMoa1012952.

12.

Trends in Hospitalizations for Intussusception in California in Relationship to the Introduction of New Rotavirus Vaccines, 1985-2010.

Contopoulos-Ioannidis DG, Halpern MS, Maldonado Y.

Pediatr Infect Dis J. 2015 Jul;34(7):712-7. doi: 10.1097/INF.0000000000000653.

PMID:
26069946
13.

Intussusception after rotavirus vaccines reported to US VAERS, 2006-2012.

Haber P, Patel M, Pan Y, Baggs J, Haber M, Museru O, Yue X, Lewis P, Destefano F, Parashar UD.

Pediatrics. 2013 Jun;131(6):1042-9. doi: 10.1542/peds.2012-2554. Epub 2013 May 13.

14.

Intussusception and Monovalent Rotavirus Vaccination in Singapore: Self-Controlled Case Series and Risk-Benefit Study.

Yung CF, Chan SP, Soh S, Tan A, Thoon KC.

J Pediatr. 2015 Jul;167(1):163-8.e1. doi: 10.1016/j.jpeds.2015.03.038. Epub 2015 Apr 14.

PMID:
25882872
15.

Trends in intussusception-associated hospitalizations and deaths among US infants.

Parashar UD, Holman RC, Cummings KC, Staggs NW, Curns AT, Zimmerman CM, Kaufman SF, Lewis JE, Vugia DJ, Powell KE, Glass RI.

Pediatrics. 2000 Dec;106(6):1413-21.

PMID:
11099597
16.

Postmarketing monitoring of intussusception after RotaTeq vaccination--United States, February 1, 2006-February 15, 2007.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2007 Mar 16;56(10):218-22.

17.
18.

Intussusception among recipients of rotavirus vaccine: reports to the vaccine adverse event reporting system.

Zanardi LR, Haber P, Mootrey GT, Niu MT, Wharton M.

Pediatrics. 2001 Jun;107(6):E97.

PMID:
11389295
19.

Potential intussusception risk versus health benefits from rotavirus vaccination in Latin America.

Desai R, Parashar UD, Lopman B, de Oliveira LH, Clark AD, Sanderson CF, Tate JE, Matus CR, Andrus JK, Patel MM.

Clin Infect Dis. 2012 May;54(10):1397-405. doi: 10.1093/cid/cis191. Epub 2012 Mar 19.

20.

Underestimates of intussusception rates among US infants based on inpatient discharge data: implications for monitoring the safety of rotavirus vaccines.

Cortese MM, Staat MA, Weinberg GA, Edwards K, Rice MA, Szilagyi PG, Hall CB, Payne DC, Parashar UD.

J Infect Dis. 2009 Nov 1;200 Suppl 1:S264-70. doi: 10.1086/605055.

Items per page

Supplemental Content

Write to the Help Desk